| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $2.0M | — | +146.5% |
| SG&A Expense | $3.9M | — | +24.9% |
| Operating Income | -$5.9M | — | -1184.2% |
| Pre-tax Income | -$11.8M | — | -229.7% |
| Net Income | -$11.8M | — | -229.7% |
| EPS (Basic) | -$0.29 | — | -112.7% |
| EPS (Diluted) | -$0.29 | — | -112.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.2M | +107.7% | -40.2% |
| Current Assets | $6.6M | +95.0% | -46.2% |
| Total Assets | $8.6M | +55.2% | -37.5% |
| Current Liabilities | $6.7M | -3.3% | -22.8% |
| Total Liabilities | $25.4M | -58.1% | +1.0% |
| Stockholders' Equity | -$16.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.6M | — | +66.7% |
| Capital Expenditures | $4K | — | +0.0% |
| Investing Cash Flow | -$4K | — | +0.0% |
| Financing Cash Flow | $5.9M | — | -68.0% |
| Free Cash Flow | -$2.6M | — | +66.6% |
| -47.9% |